Lane Kiffin and the LSU Tigers continue tinkering the staff in Baton Rouge with a myriad of moving parts occurring behind the scenes. After Kiffin arrived in th ...
D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round.
What do you do when you’re passionate about everything? You do everything. Adam Boaks steps up as an educator, club advisor, ...
RMAT designation indicates that SENTI-202 has the potential to address unmet medical needs for patients with Relapsed/Refractory (R/R) Acute ...
ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high ...
NEW ORLEANS - Researchers at the LSU LCMC Health Cancer Center have published groundbreaking findings in the medical journal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results